Patents by Inventor Joon Woo Nam

Joon Woo Nam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11919122
    Abstract: A substrate processing apparatus includes: a conveyor belt configured to have an outer surface on which a bottom surface of a substrate is seated; and a polishing head unit configured to face an upper surface of the substrate, wherein the polishing head unit includes: a polishing head connected to a driver; a polishing pad configured to face the polishing head; a polishing pad fixing ring disposed between the polishing head and the polishing pad; and a temperature sensor configured to overlap the polishing pad fixing ring and to be spaced apart from the polishing pad fixing ring.
    Type: Grant
    Filed: September 29, 2020
    Date of Patent: March 5, 2024
    Assignees: SAMSUNG DISPLAY CO., LTD., KCTECH CO., LTD.
    Inventors: Seung Bae Kang, Sung Hyeon Park, Jung Gun Nam, Joon-Hwa Bae, Kyung Bo Lee, Keun Woo Lee, Woo Jin Cho, Byoung Kwon Choo
  • Patent number: 10752604
    Abstract: The present disclosure relates to C-glycoside derivatives having a fused phenyl ring or pharmaceutical acceptable salts thereof, a method for preparing the same, a pharmaceutical composition comprising the same, a use thereof and a method for dual inhibition of SGLT1 and SGLT2 using the same. A novel compound of the present disclosure has a dual inhibitory activity against SGLT1 and SGLT2, thus being valuably used as a diabetes therapeutic agent.
    Type: Grant
    Filed: January 3, 2017
    Date of Patent: August 25, 2020
    Assignee: Je II Pharmaceutical Co., Ltd.
    Inventors: Joon Woo Nam, Jong Yup Kim, Kyung Hoon Kim, Jung Mee Lee, Ji Yoon Kim, Ji Seon Park, Joseph Kim, Yoon Sun Park, Jeong Min Kim
  • Publication number: 20190002425
    Abstract: The present disclosure relates to C-glycoside derivatives having a fused phenyl ring or pharmaceutical acceptable salts thereof, a method for preparing the same, a pharmaceutical composition comprising the same, a use thereof and a method for dual inhibition of SGLT1 and SGLT2 using the same. A novel compound of the present disclosure has a dual inhibitory activity against SGLT1 and SGLT2, thus being valuably used as a diabetes therapeutic agent.
    Type: Application
    Filed: January 3, 2017
    Publication date: January 3, 2019
    Inventors: Joon Woo Nam, Jong Yup Kim, Kyung Hoon Kim, Jung Mee Lee, Ji Yoon Kim, Ji Seon Park, Joseph Kim, Yoon Sun Park, Jeong Min Kim